Application of estimand framework in ICH E9 (R1) to safety evaluation

3Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Defining the right question of interest is important to a clinical study. ICH E9 (R1) introduces the framework of an estimand and its five attributes, which provide a basis for connecting different components of a study with its clinical questions. Most of the applications of the estimand framework focus on efficacy instead of safety assessment. In this paper, we expand the estimand framework into the safety evaluation and compare/contrast the similarity and differences between safety and efficacy estimand. Furthermore, we present and discuss applications of a safety estimand to oncology trials and pooled data analyses. At last, we also discuss the potential usage of safety estimand to handle the impacts of COVID-19 pandemic on safety assessment.

Cite

CITATION STYLE

APA

Wang, X., Yang, P., Yuan, S. S., & Wang, W. W. B. (2023). Application of estimand framework in ICH E9 (R1) to safety evaluation. Journal of Biopharmaceutical Statistics, 33(4), 476–487. https://doi.org/10.1080/10543406.2023.2189452

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free